Education
About Us
Working with TipRanks
Follow Us
Amplifon S.p.A. (GB:0N61)
LSE:0N61
0N61 Stock Chart & Stats
€8.07
-€0.64(-2.45%)
At close: 4:00 PM EST
€8.07
-€0.64(-2.45%)
Day’s Range― - ―
52-Week Range€7.84 - €21.47
Previous CloseN/A
Volume73.02K
Average Volume (3M)88.45K
Market Cap
€1.81B
Enterprise Value€3.30B
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€1.53B
Price to Earnings (P/E)34.1
Beta1.18
Next Earnings
May 05, 2026EPS Estimate
0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding226,388,630
10 Day Avg. Volume39,207
30 Day Avg. Volume88,446
Financial Highlights & Ratios
PEG Ratio-0.91
Price to Book (P/B)3.12
Price to Sales (P/S)1.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€8.95Price Target Upside10.90% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)0.79
Revenue Forecast (FY)€2.45B
Bulls Say, Bears Say
Bulls Say
Large Global Clinic NetworkA broad international clinic footprint creates a durable competitive advantage: local presence drives patient acquisition, high-touch fittings raise conversion and retention, and scale supports purchasing leverage for devices and standardized clinical processes that sustain margins over time.
Recurring Service Revenue StreamAfter-sales services and consumables generate recurring, higher-margin revenue and increase customer lifetime value. This business model reduces reliance on one-off device sales, smoothing cash flows and creating long-term revenue resilience through repeat clinic visits and service contracts.
Prior Multi-year Free Cash Flow Track RecordHistorically consistent free cash flow (2020–2024) demonstrates the company’s ability to convert earnings into cash, supporting reinvestment, dividends and deleveraging potential. That track record underpins financial flexibility if cash conversion normalizes beyond short-term shocks.
Bears Say
Margin Compression And Falling ProfitabilitySustained margin erosion materially weakens long-term return on capital and limits the company’s ability to fund growth or sustain payouts. Declining gross and net margins suggest competitive pressure or cost structure issues that could persist absent structural remediation.
Elevated Leverage Limits FlexibilityA relatively debt-heavy capital structure reduces capacity to invest, pursue M&A, or absorb cyclical shocks without raising costs. Persistent leverage narrows strategic optionality and raises refinancing and interest-rate sensitivity over the medium term.
Weakening Cash Conversion; Zero FCF In 2025A collapse in free cash flow to zero is a durable concern: reduced internal funding capacity limits capex, dividend sustainability and deleveraging. If cash conversion problems reflect structural working-capital or pricing issues, recovery could be slow and capital-constrained.
Amplifon S.p.A. News
0N61 FAQ
What was Amplifon S.p.A.’s price range in the past 12 months?
Amplifon S.p.A. lowest share price was €7.84 and its highest was €21.47 in the past 12 months.
What is Amplifon S.p.A.’s market cap?
Amplifon S.p.A.’s market cap is €1.81B.
When is Amplifon S.p.A.’s upcoming earnings report date?
Amplifon S.p.A.’s upcoming earnings report date is May 05, 2026 which is in 46 days.
How were Amplifon S.p.A.’s earnings last quarter?
Amplifon S.p.A. released its earnings results on Mar 04, 2026. The company reported €0.23 earnings per share for the quarter, beating the consensus estimate of €0.228 by €0.002.
Is Amplifon S.p.A. overvalued?
According to Wall Street analysts Amplifon S.p.A.’s price is currently Undervalued.
Does Amplifon S.p.A. pay dividends?
Amplifon S.p.A. does not currently pay dividends.
What is Amplifon S.p.A.’s EPS estimate?
Amplifon S.p.A.’s EPS estimate is 0.14.
How many shares outstanding does Amplifon S.p.A. have?
Amplifon S.p.A. has 226,388,630 shares outstanding.
What happened to Amplifon S.p.A.’s price movement after its last earnings report?
Amplifon S.p.A. reported an EPS of €0.23 in its last earnings report, beating expectations of €0.228. Following the earnings report the stock price went down -2.179%.
Which hedge fund is a major shareholder of Amplifon S.p.A.?
Currently, no hedge funds are holding shares in GB:0N61
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amplifon S.p.A.
Amplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound. The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices. It also provides fitting of customized products. As of March 18, 2022, the company operated a network of approximately 9,200 points of sale in 25 countries and 5 continents. The company also sells its products through 1,350 franchisees. It has operations in Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company was founded in 1950 and is headquartered in Milan, Italy.
0N61 Stock 12 Month Forecast
Average Price Target
€8.95
▲(10.90% Upside)
Technical Analysis
PharmaNutra SpA
―
Health Italia SpA
―
Garofalo Health Care S.P.A.
―
GPI SpA
―
Svas Biosana S.p.A.
―
Options Prices
Currently, No data available
---